Content about Medicinal chemistry

December 23, 2013

The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

CAMBRIDGE, Mass. — The Food and Drug Administration has approved revisions to the labeling of a leukemia drug made by Ariad Pharmaceuticals that allow the company to resume selling it, the company said.

December 13, 2013

The National Association of Chain Drug Stores underscored its commitment to improving the quality and affordability of the nation’s healthcare system and expressed concern about potential consequences of restricted pharmacy networks with the Patient Protection and Affordable Care Act exchange plans.

ARLINGTON, Va. — The National Association of Chain Drug Stores underscored its commitment to improving the quality and affordability of the nation’s healthcare system and expressed concern about potential consequences of restricted pharmacy networks with the Patient Protection and Affordable Care Act exchange plans in a statement to the U.S. House of Representatives Oversight and Government Reform Committee. 

The committee held a hearing Friday titled, “Premiums, Provider Networks and the Health Care Law.”


December 9, 2013

Pharmacy Quality Solutions on Monday announced that it will collaborate with Cardinal Health to help 600 community pharmacies track their performance on Medicare Part D Star measures.

SPRINGFIELD, Va. — Pharmacy Quality Solutions on Monday announced that it will collaborate with Cardinal Health to help 600 community pharmacies track their performance on Medicare Part D Star measures. 

December 6, 2013

Health Mart, a community franchise of more than 3,000 independently owned pharmacies across all 50 states, announced that it will offer its member pharmacies access to Pharmacy Quality Solutions' EQuIPP.

SAN FRANCISCO — Health Mart, a community franchise of more than 3,000 independently owned pharmacies across all 50 states, on Friday announced that it will offer its member pharmacies access to Pharmacy Quality Solutions' EQuIPP, an online information management platform that makes pharmacy performance data available to health plans and community pharmacy organizations. 

December 6, 2013

McKesson's Health Mart pharmacy franchisees recently gained access to a tool that has the potential of giving community pharmacy a leg up on the competition in the coming years. EQuIPP, from Pharmacy Quality Solutions, does just that — equips independents with individual store data that marks the performance of their pharmacy vs. a national benchmark.

It's putting the pestle where the mortar is — retail pharmacy has the patient touchpoints and data-tracking wherewithal to make a material impact on patient outcomes. Important, because that's what the new year will bring — more and more healthcare payers looking to improve their own patient outcomes. And what better way to do it than to partner with outperforming pharmacies?

McKesson's Health Mart pharmacy franchisees recently gained access to a tool that has the potential of giving community pharmacy a leg up on the competition in the coming years. EQuIPP, from Pharmacy Quality Solutions, does just that — equips independents with individual store data that marks the performance of their pharmacy vs. a national benchmark. 

December 4, 2013

Mail-order pharmacies frequently charge Medicare prescription drug plans more than community pharmacies do for filling prescriptions, a new analysis by the U.S. Centers for Medicare and Medicaid Services has concluded.

ALEXANDRIA, Va. — Mail-order pharmacies frequently charge Medicare prescription drug plans more — as much as 83% — than community pharmacies do for filling prescriptions, a new analysis by the U.S. Centers for Medicare and Medicaid Services has concluded.

CMS examined claims from March 2012 and found 21 drug plans that routinely paid more for prescriptions filled through the mail compared to a community pharmacy.

December 4, 2013

The Food and Drug Administration has approved a new topical drug for treating scars made by Oculus Innovative Sciences, the drug maker said Wednesday.

PETALUMA, Calif. — The Food and Drug Administration has approved a new topical drug for treating scars made by Oculus Innovative Sciences, the drug maker said Wednesday.

The FDA has approved Microcyn scar-management hydrogel, used to treat scars resulting from burns, surgery and trauma wounds. Oculus and a partnering company, Quinnova Pharmaceuticals, intend to start selling the drug in the first half of next year.

December 3, 2013

Cardinal Health recently enhanced its Reimbursement Consulting Services offering, which helps retail pharmacies ensure the accuracy of third-party reimbursement by identifying reimbursement errors and recommending strategies for correcting them.

DUBLIN, Ohio — Cardinal Health recently enhanced its Reimbursement Consulting Services offering, which helps retail pharmacies ensure the accuracy of third-party reimbursement by identifying reimbursement errors and recommending strategies for correcting them, the wholesaler announced Tuesday.

According to the NCPA Digest, sponsored by Cardinal Health, independent pharmacies derive 92% of their revenue from prescription reimbursements. However, a number of factors can impact a retail pharmacy’s ability to ensure they receive the reimbursement they’re owed.

December 3, 2013

McKesson will be introducing hospital and health systems pharmacy leaders to new ideas and emerging solutions for their top issues at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2013, which runs from Dec. 8 to 12.

SAN FRANCISCO — McKesson will be introducing hospital and health systems pharmacy leaders to new ideas and emerging solutions for their top issues at the American Society of Health-System Pharmacists Midyear Clinical Meeting 2013, which runs from Dec. 8 to 12. Organized under the theme “Learn, Network, Solve,” McKesson booth #849 will host solution demonstrations and live interviews, and pharmacy consulting experts will be on hand for one-on-one discussions designed to help pharmacy leaders drive better business health, the wholesaler stated.

December 2, 2013

Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

WASHINGTON — Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn't, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.

November 27, 2013

The National Association of Chain Drug Stores has issued a statement regarding the participation of NACDS president and CEO Steve Anderson in a White House meeting Tuesday regarding implementation of the Patient Protection and Affordable Care Act.

ARLINGTON, Va. — The National Association of Chain Drug Stores has issued a statement regarding the participation of NACDS president and CEO Steve Anderson in a White House meeting Tuesday regarding implementation of the Patient Protection and Affordable Care Act.

According to NACDS, the statement reads:

November 25, 2013

Executives from retail, manufacturing, regulation and others are among the four new appointees to the Pharmacy Quality Alliance's board of directors for next year, the group said Monday.

SPRINGFIELD, Va. — Executives from retail, manufacturing, regulation and others are among the four new appointees to the Pharmacy Quality Alliance's board of directors for next year, the group said Monday.

November 20, 2013

Navarro Discount Pharmacy has been selected by OutcomesMTM as 1-of-4 pharmacies in the Southeast region recognized for its commitment to patient therapy management and the health of its patients.

MIAMI — Navarro Discount Pharmacy has been selected by OutcomesMTM as 1-of4 pharmacies in the Southeast region recognized for its commitment to patient therapy management and the health of its patients.

“We are honored to receive this recognition which highlights our continued commitment to patient health, education and the individualized attention we provide our patients on a daily basis,” Albert Garcia, EVP of pharmacy at Navarro Discount Pharmacy stated. OutcomesMTM designs, delivers and administers MTM programs.

November 15, 2013

The Food and Drug Administration has approved an OTC personal lubricant that helps couples conceive more easily.

CHICAGO — The Food and Drug Administration has approved an OTC personal lubricant that helps couples conceive more easily.

Sasmar announced Friday the FDA approval of Conceive Plus, described as an isotonic, fertility-friendly personal lubricant that helps increase a woman's chances of getting pregnant naturally. The patent-pending formula is pH balanced to mimic fertile fluids and semen and contains minerals helpful to fertilization.

November 15, 2013

The value of drugs approved in the United States this year could reach almost $19 billion in sales five years after their launch, exceeding the value of drugs approved in 2012, according to a new report.

NEW YORK — The value of drugs approved in the United States this year could reach almost $19 billion in sales five years after their launch, exceeding the value of drugs approved in 2012, according to a new report.

November 12, 2013

Walgreens recently presented research from two retrospective cohort studies exploring HIV and comorbid medication adherence at HIV-specialized pharmacies and the implications for HIV patients with serious mental illness.

DEERFIELD, Ill. — Walgreens recently presented research from two retrospective cohort studies exploring HIV and comorbid medication adherence at HIV-specialized pharmacies and the implications for HIV patients with serious mental illness. The research, presented at the Cell-Lancet conference, "What Will it Take to Achieve an AIDS-free World?," in San Francisco Nov.

November 8, 2013

Sanofi-Aventis has sued the Food and Drug Administration to keep its labeling for OTC Nasacort confidential in an effort to delay store brand competition until after the launch, according to an entry in the FDA Law Blog, the official blog of Hyman, Phelps & McNamara, published Thursday.

WASHINGTON — Sanofi-Aventis has sued the Food and Drug Administration to keep its labeling for OTC Nasacort confidential in an effort to delay store brand competition until after the launch, according to an entry in the FDA Law Blog, the official blog of Hyman, Phelps & McNamara, published Thursday. 

November 8, 2013

It’s called medication synchronization, and the concept is simple enough — shifting patients to a synchronized, easy-to-comply-with, once-a-month prescription refill program so they can pick up all their medications with one visit to the pharmacy each month, instead of multiple trips.

It’s called medication synchronization, and the concept is simple enough — shifting patients to a synchronized, easy-to-comply-with, once-a-month prescription refill program so they can pick up all their medications with one visit to the pharmacy each month, instead of multiple trips.

November 8, 2013

PharmaSmart's kiosks will be integrated with PDX's Enterprise Pharmacy System, allowing pharmacies with the EPS system to collect data from patients through the kiosks, under a partnership between the two companies announced Friday.

FORT WORTH, Texas — PharmaSmart's kiosks will be integrated with PDX's Enterprise Pharmacy System, allowing pharmacies with the EPS system to collect data from patients through the kiosks, under a partnership between the two companies announced Friday.

November 8, 2013

Higi ‘scores’ with kiosks

Through its biometric screening kiosks, its smartphone application and its website, Higi encourages users to take a more holistic approach to their health. True wellness, its creators insist, springs not just from such physical metrics as blood pressure, glucose readings and body mass index, but from lifestyle choices and connections to family, friends, neighbors and coworkers.

November 7, 2013

Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take.

PORTLAND, Ore. — Aisle7 on Thursday announced the launch of Healthnotes Interactions Checker, a next-generation solution simplifying the task of deciding which nutrients positively or negatively interact with the medicines they take. More than half of all Americans take some form of dietary supplement, and an estimated 40% of U.S. adults take both drugs and nutrients as part of their health regimen. Of these, 60% aren’t discussing possible interactions with their physician or pharmacist, Aisle7 noted. 

November 6, 2013

McKesson's Health Mart on Wednesday announced the launch of its new Local Marketing Support program designed to make it easier for Health Mart owners to grow their business by attracting new patients and driving revenue.

SAN FRANCISCO — McKesson's Health Mart on Wednesday announced the launch of its new Local Marketing Support program, designed to make it easier for Health Mart owners to grow their business by attracting new patients and driving revenue. The Local Marketing Support program provides matching funds and comprehensive marketing tools and campaigns, letting Health Mart owners increase awareness of their stores and community care offerings.   

November 5, 2013

The Food and Drug Administration has approved a generic injectable antibiotic drug made by Emcure Pharmaceuticals, according to the agency.

SILVER SPRING, Md. – The Food and Drug Administration has approved a generic injectable antibiotic drug made by Emcure Pharmaceuticals, according to the agency.

The FDA approved Emcure's vancomycin hydrochloride injection in the 5-g-per-vial strength.

The drug is a generic version of Vancocin, made by ViroPharma.

 

November 4, 2013

The Food and Drug Administration has asked Ariad Pharmaceuticals to suspend marketing and sales of a chemotherapy drug for leukemia due to the risk of life-threatening side effects, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has asked Ariad Pharmaceuticals to suspend marketing and sales of a chemotherapy drug for leukemia due to the risk of life-threatening side effects, the agency said.

October 31, 2013

Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze gel.

HAYWARD, Calif., and FORT COLLINS, Colo.  — Impax Labs and Tolmar announced that the Food and Drug Administration has given final approval to Tolmar's generic version of Solaraze (diclofenac sodium) gel in the 3% strength.